| |
| | Tissue engineering - Nature Biotechnology |
 | | Tissue and organ failure, produced as a result of injury or other type of damage, is a major health problem, accounting for about half of the total annual expenditure in health care in the US Treatment options include transplantation (human or xenotransplantation), surgical repair, artificial prostheses, mechanical devices, and in a few cases, drug therapy. |
 | | Tissue engineering is emerging as a significant potential alternative or complementary solution, whereby tissue and organ failure is addressed by implanting natural, synthetic, or semisynthetic tissue and organ mimics that are fully functional from the start, or that grow into the required functionality. |
 | | Chondrocytes are constituents of cartilagenous tissue, and the possibility of generating them in a controlled fashion creates possibilities for the development of appropriate cartilage tissue for surgical procedures. |
| www.nature.com /cgi-taf/DynaPage.taf?file=/nbt/journal/v18/n10s/full/nbt1000_IT56.html (2344 words) |
|